European Review for Medical and Pharmacological Sciences

European Review for Medical
and Pharmacological Sciences

European Review for Medical and Pharmacological Sciences, a fortnightly journal, acts as an information exchange tool on several aspects of medical and pharmacological sciences. It publishes reviews, original articles, and results from original research.

The purposes of the Journal are to encourage interdisciplinary discussions and to contribute to the advancement of medicine.

We encourage scientists from all around the world to submit their research regarding PACS (Post-Acute COVID-19 Syndrome).
Any contribution is important for the Scientific Community.

The full text of the articles can be downloaded free of charge.

Indexed in PubMed

CiteScore: 6.3

Issues Archive - Page 263

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3166-3173
DOI: 10.26355/eurrev_202003_20683

MiR-92b inhibits proliferation and invasion of lung cancer by targeting EZH2

L. Chen, H.-Z. Zhuo, J.-Y. Wu, L.-Y. Lin, Z.-L. Huang, J.-X. Lu, K.-L. Cheng
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3152-3165
DOI: 10.26355/eurrev_202003_20682

Down-regulation of long non-coding RNA DUXAP8 suppresses proliferation, metastasis and EMT by modulating miR-498 through TRIM44-mediated AKT/mTOR pathway in non-small-cell lung cancer

X. Ji, R. Tao, L.-Y. Sun, X.-L. Xu, W. Ling
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3143-3151
DOI: 10.26355/eurrev_202003_20681

USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4

X.-H. Liao, Y. Wang, B. Zhong, S.-Y. Zhu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3130-3142
DOI: 10.26355/eurrev_202003_20680

ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway

X.-H. Xiao, S.-Y. He
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3122-3129
DOI: 10.26355/eurrev_202003_20679

MiR-193 promotes cell proliferation and invasion by ING5/PI3K/AKT pathway of triple-negative breast cancer

J.-H. Xu, J.-X. Zhao, M.-Y. Jiang, L.-P. Yang, M.-L. Sun, H.-W. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3113-3121
DOI: 10.26355/eurrev_202003_20678

MiR-526b suppresses cell proliferation, cell invasion and epithelial-mesenchymal transition in breast cancer by targeting Twist1

Y.-Q. Liu, Y.-Z. Cong, J. Jiang, J.-Z. Sheng, X.-H. Li, M. Zhao, M.-Y. Peng
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3105-3112
DOI: 10.26355/eurrev_202003_20675

MiR-548b-3p inhibits proliferation and migration of breast cancer cells by targeting MDM2

M.-X. Sha, X.-W. Huang, Q. Yin
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3097-3104
DOI: 10.26355/eurrev_202003_20674

Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT

J.-L. Zhou, L. Zou, T. Zhu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3085-3096
DOI: 10.26355/eurrev_202003_20673

KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis

Y. Zhang, J.-L. Liu, J. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3077-3084
DOI: 10.26355/eurrev_202003_20672

Long non-coding RNA GNAS-AS1 promotes cell migration and invasion via regulating Wnt/β-catenin pathway in nasopharyngeal carcinoma

X.-Q. Wang, H. Xu, C.-H. Wang, H. Xie
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3069-3076
DOI: 10.26355/eurrev_202003_20671

Hsa_circ_001193 regulates proliferation and apoptosis of nasopharyngeal carcinoma cells through targeting mir-496

K.-J. Ke, C.-Y. Wang, P. Li, X.-W. Huang, S.-L. Zhang, X. Li, X.-F. Cui
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3062-3068
DOI: 10.26355/eurrev_202003_20670

Clinical significance of TBX2 in esophageal squamous cell carcinomas and its role in cell migration and invasion

R. Hu, J. Deng, C. Li, C. Xu, Z.-H. Cui, J. Zhao
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3049-3061
DOI: 10.26355/eurrev_202003_20669

The long non-coding RNA DDX11-AS1 facilitates cell progression and oxaliplatin resistance via regulating miR-326/IRS1 axis in gastric cancer

W. Song, Y. Qian, M.-H. Zhang, H. Wang, X. Wen, X.-Z. Yang, W.-J. Dai
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3037-3048
DOI: 10.26355/eurrev_202003_20668

Long non-coding RNA FTX promotes gastric cancer progression by targeting miR-215

F. Zhang, X.-S. Wang, B. Tang, P.-A. Li, Y. Wen, P.-W. Yu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3030-3036
DOI: 10.26355/eurrev_202003_20667

Association between hsa_circ_0006156 expression and incidence of gastric cancer

Y.-X. He, H. Ju, N. Li, Y.-F. Jiang, W.-J. Zhao, T.-T. Song, W.-H. Ren
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3023-3029
DOI: 10.26355/eurrev_202003_20666

Low expression of lncRNA TUBA4B promotes proliferation and inhibits apoptosis of colorectal cancer cells via regulating P15 and P16 expressions

Y.-G. Zhou, F. Sun, Y.-F. Zhou
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 3004-3022
DOI: 10.26355/eurrev_202003_20665

Hsa_circ_0007534 knockdown represses the development of colorectal cancer cells through regulating miR-613/SLC25A22 axis

D.-Y. Ding, D. Wang, Z.-B. Shu
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 2994-3003
DOI: 10.26355/eurrev_202003_20664

Influence of KRAS mutations on clinical outcome in patients with curatively resected stage III colon cancer treated with adjuvant chemotherapy

S. De Dosso, M. Nucifora, N. Sahnane, S. Epistolio, M.E. Riveiro, V. Bertolini, E. Bucci, R. Boldorini, S. Freguia, M. Frattini, P. Saletti
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 2986-2993
DOI: 10.26355/eurrev_202003_20663

Promoting effect of PAX5-activated lncRNA UASR1 on growth of colorectal cancer by regulating the mTOR pathway

W. Wang, Z. Wang, H. Wang, X. Li, H.-T. Wang
Free PDF Download

Eur Rev Med Pharmacol Sci 2020; 24 (6): 2977-2985
DOI: 10.26355/eurrev_202003_20662

STYXL1 promotes malignant progression of hepatocellular carcinoma via downregulating CELF2 through the PI3K/Akt pathway

J.-Z. Wu, N. Jiang, J.-M. Lin, X. Liu
Free PDF Download